A new drug called Letairis (ambrisentan) plus new guidelines are updating treatment for pulmonary arterial hypertension
August 2007
Please see the August 2012 FDA warning concerning the use of Revatio in children with PAH
In pulmonary arterial hypertension, there is continuous high blood pressure in the pulmonary arteries...which carry oxygen-poor blood from the right ventricle to the lungs.
It's a rare condition that's due to tightening of pulmonary arteries...thickening of the walls of pulmonary arteries...or to blockages caused by blood clots in smaller arteries.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote